GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | September 04, 2024 |
PDB ID | UniProt ID | Title | Descriptor ▲ |
---|---|---|---|
6U3N | O19705 | LS2.8/3.15 - DQ2-P.fluor-alpha1a complex | |
6U3N | O19712 | LS2.8/3.15 - DQ2-P.fluor-alpha1a complex | |
6U3N | 6U3N | LS2.8/3.15 - DQ2-P.fluor-alpha1a complex | |
6U77 | P27472 | yGsy2p in complex with small molecule | |
6U7F | P15144 | HCoV-229E RBD Class IV in complex with human APN | |
6U7F | 6U7F | HCoV-229E RBD Class IV in complex with human APN | |
6UAU | G0FQ07 | Crystal structure of a GH128 (subgroup I) endo-beta-1,3-glucanase (E102A mutant) from Amycolatopsis mediterranei (AmGH128_I) in complex with laminaritriose and laminaribiose | |
6UB0 | A0A179UGT5 | Crystal structure of a GH128 (subgroup III) curdlan-specific exo-beta-1,3-glucanase from Blastomyces gilchristii (BgGH128_III) in complex with laminaribiose at -2 and -1 subsites | |
6UBA | A0A074W9U7 | Crystal structure of a GH128 (subgroup VI) exo-beta-1,3-glucanase from Aureobasidium namibiae (AnGH128_VI) in complex with laminaritriose | |
6UBB | A0A074W9U7 | Crystal structure of a GH128 (subgroup VI) exo-beta-1,3-glucanase from Aureobasidium namibiae (AnGH128_VI) with laminaribiose at the surface-binding site | |
6UG8 | 6UG8 | Complex of ch28/11 Fab and SSEA-4 (monoclinic form) | |
6UIG | A0A4Y5QYN9 | Crystal structure of human monoclonal antibody H7.200 in complex with H7N9 hemagglutinin HA1 | |
6UIG | 6UIG | Crystal structure of human monoclonal antibody H7.200 in complex with H7N9 hemagglutinin HA1 | |
6UIQ | P36871 | Crystal structure of wild-type human phosphoglucomutase 1 in complex with Glucose-6-Phosphate | |
6UL7 | P50053 | Structure of human ketohexokinase-C in complex with fructose, NO3, and osthole | |
6UQR | 6UQR | Complex of IgE and Ligelizumab | |
6UQR | P01854 | Complex of IgE and Ligelizumab | |
6UR5 | 6UR5 | Resurfaced influenza hemagglutinin in complex with a broadly neutralizing antibody | |
6URM | A0A3S7XTA4 | Crystal structure of vaccine-elicited receptor-binding site targeting antibody LPAF-a.01 in complex with Hemagglutinin H1 A/California/04/2009 | |
6URM | 6URM | Crystal structure of vaccine-elicited receptor-binding site targeting antibody LPAF-a.01 in complex with Hemagglutinin H1 A/California/04/2009 | |
6USC | Q8WWA0 | Structure of Human Intelectin-1 in complex with KO | |
6UT1 | A0A0M3KKW9 | CRYSTAL STRUCTURE OF HIV-1 LM/HS CLADE A/E CRF01 GP120 CORE IN COMPLEX WITH BNM-III-170 | |
6UTK | 6UTK | Crystal structure of 438-B11 Fab in complex with an uncleaved prefusion optimized (UFO) soluble BG505 trimer and Fab 35O22 at 3.80 Angstrom | |
6UTK | Q2N0S6 | Crystal structure of 438-B11 Fab in complex with an uncleaved prefusion optimized (UFO) soluble BG505 trimer and Fab 35O22 at 3.80 Angstrom | |
6UTK | Q2N0S9 | Crystal structure of 438-B11 Fab in complex with an uncleaved prefusion optimized (UFO) soluble BG505 trimer and Fab 35O22 at 3.80 Angstrom | |
6UUD | 6UUD | Crystal structure of antibody 5D5 in complex with PfCSP N-terminal peptide | |
6UUH | 6UUH | Crystal structure of broad and potent HIV-1 neutralizing antibody 438-B11 | |
6UUH | P19909 | Crystal structure of broad and potent HIV-1 neutralizing antibody 438-B11 | |
6UYF | 6UYF | Structure of Hepatitis C Virus Envelope Glycoprotein E2mc3-v1 redesigned core from genotype 6a bound to broadly neutralizing antibody AR3B | |
6V19 | P01903 | immune receptor complex | |
6V19 | P13760 | immune receptor complex | |
6V19 | 6V19 | immune receptor complex | |
6V1C | Q07654 | Crystal structure of human trefoil factor 3 in complex with its cognate ligand | |
6V2E | P0AEX9 | Crystal structure of the human CLR:RAMP2 extracellular domain heterodimer with bound high-affinity adrenomedullin S45R/K46L/S48G/Q50W variant | |
6V2E | O60895 | Crystal structure of the human CLR:RAMP2 extracellular domain heterodimer with bound high-affinity adrenomedullin S45R/K46L/S48G/Q50W variant | |
6V2E | Q16602 | Crystal structure of the human CLR:RAMP2 extracellular domain heterodimer with bound high-affinity adrenomedullin S45R/K46L/S48G/Q50W variant | |
6V2E | P35318 | Crystal structure of the human CLR:RAMP2 extracellular domain heterodimer with bound high-affinity adrenomedullin S45R/K46L/S48G/Q50W variant | |
6V74 | P14618 | Crystal Structure of Human PKM2 in Complex with L-asparagine | |
6V75 | P14618 | Crystal Structure of Human PKM2 in Complex with L-aspartate | |
6V76 | P14618 | Crystal Structure of Human PKM2 in Complex with L-valine | |
6V80 | P15813 | Crystal structure of human CD1d presenting alpha-Galactosylceramide in complex with NKT12 TCR and VHH nanobody 1D12 | |
6V80 | 6V80 | Crystal structure of human CD1d presenting alpha-Galactosylceramide in complex with NKT12 TCR and VHH nanobody 1D12 | |
6V80 | P15813 | Crystal structure of human CD1d presenting alpha-Galactosylceramide in complex with NKT12 TCR and VHH nanobody 1D12 | |
6V80 | 6V80 | Crystal structure of human CD1d presenting alpha-Galactosylceramide in complex with NKT12 TCR and VHH nanobody 1D12 | |
6V80 | P61769 | Crystal structure of human CD1d presenting alpha-Galactosylceramide in complex with NKT12 TCR and VHH nanobody 1D12 | |
6V80 | K7N5M3 | Crystal structure of human CD1d presenting alpha-Galactosylceramide in complex with NKT12 TCR and VHH nanobody 1D12 | |
6V80 | A0A0B4J240 | Crystal structure of human CD1d presenting alpha-Galactosylceramide in complex with NKT12 TCR and VHH nanobody 1D12 | |
6V80 | K7N5M4 | Crystal structure of human CD1d presenting alpha-Galactosylceramide in complex with NKT12 TCR and VHH nanobody 1D12 | |
6VBG | C6FW78 | Lactose permease complex with thiodigalactoside and nanobody 9043 | |
6VBG | 6VBG | Lactose permease complex with thiodigalactoside and nanobody 9043 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024